查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1651021

全球栓塞保护装置市场

Embolic Protection Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球栓塞防护装置市场规模将达到 21 亿美元

2024 年全球栓塞防护装置市场规模估计为 14 亿美元，预计 2030 年将达到 21 亿美元，2024 年至 2030 年的复合年增长率为 6.6%。远端过滤器是报告中分析的细分市场，预计其复合年增长率为 7.6%，在分析期结束时达到 13 亿美元。预计在分析期内，近端闭塞段的成长率为 4.3%。

美国市场规模估计为 3.999 亿美元，中国市场预计复合年增长率为 6.2%

预计到 2024 年美国栓塞防护装置市值将达到 3.999 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 3.268 亿美元，2024-2030 年分析期间的复合年增长率为 6.2%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 6.3% 和 5.2%。在欧洲，德国的复合年增长率预计为 5.2%。

全球栓塞保护装置市场 - 主要趋势和驱动因素摘要

栓塞保护装置如何彻底改变心血管照护？

栓塞保护装置 (EPD) 正在彻底改变心血管护理，显着提高经皮冠状动脉介入治疗 (PCI) 和经导管主动脉瓣置换术(TAVR) 等手术的安全性和有效性。这些装置专门用于捕获和清除在干预过程中可能脱落的栓塞碎片，防止碎片进入血液并引起中风、心肌梗塞或器官损伤等併发症。因此，EPD 可以降低与心血管手术相关的主要风险之一，特别是对于更容易发生栓塞事件的高风险患者。此类设备的引入降低了手术併发症的发生率，改善了患者的治疗效果，使得复杂的心血管手术更加安全、有效。随着全球心血管疾病负担不断增加，栓塞保护装置在确保患者安全和提高手术成功率方面的作用在现代心血管护理中变得越来越重要。

哪些创新正在提高栓塞防护装置的功能？

栓塞保护装置的创新正在透过设计、材料和与其他心血管技术的结合的进步来提高其功能。最重要的进展之一是这些设备的小型化，使得它们能够以更高的精度和最小的干扰被放置在更小的血管中。这在颈动脉支架置入术等手术中尤其重要，因为该类手术中中风的风险很高，精确放置至关重要。此外，使用生物相容性聚合物和细网过滤器等先进材料，提高了 EPD 捕获最小栓塞颗粒的能力，而不会阻碍血流。这导致了更有效、更患者友好的设备的开发，这些设备可以降低併发症的风险并缩短恢復时间。此外，栓塞保护装置与血管内超音波(IVUS) 和光同调断层扫瞄(OCT) 等影像技术的结合，可实现手术过程中的即时可视化。这种整合使临床医生能够精确定位 EPD 并监测其性能，确保对栓塞事件提供最佳的保护。这些创新使得栓塞保护装置更有效率、更容易使用和更安全，增强了其在广泛心血管干预中的作用。

栓塞保护装置如何影响病人结果和手术安全？

栓塞保护装置可显着降低心臟介入治疗期间发生栓塞併发症的风险，对病患治疗结果和手术安全有重大影响。在颈动脉支架置入术、TAVR和PCI等手术过程中，脱落的斑块和血栓可能导致严重的併发症，包括中风和心臟病发作。透过在这些碎片到达大脑或冠状动脉等关键部位之前将其捕获，EPD 大大降低了这些不利事件的发生率。这种改进的安全性不仅改善了患者的治疗效果，而且扩大了适合微创心血管手术的患者群体，包括先前被认为是高风险的患者。此外，使用 EPD 意味着患者会经历更少的併发症，需要更少的加护治疗，从而缩短住院时间并加快康復时间。对于医疗保健提供者来说，降低手术风险和相关併发症意味着提高整体成功率并降低医疗成本。栓塞保护装置透过避免心血管护理中最重大的风险之一，在改善患者照护和使救生程序更安全方面发挥关键作用。

哪些趋势推动了栓塞防护装置市场的成长？

推动栓塞保护装置市场成长的趋势包括心血管疾病盛行率的不断上升、微创手术的日益普及以及医疗技术的不断进步。动脉粥状硬化、心臟瓣膜疾病、颈动脉狭窄等疾病的发生率不断上升，导致介入心臟病学的数量增加，从而推动了对 EPD 的需求。随着世界人口老化和心血管疾病负担增加，对安全有效的治疗方案的需求变得越来越重要。向 TAVR 和颈动脉支架置入术等微创手术的转变也刺激了市场成长。这些手术通常涉及栓塞事件的高风险，因此 EPD 对确保患者安全至关重要。此外，设备设计的不断进步，例如开发具有增强过滤和改进输送系统的下一代 EPD，正在扩大这些设备的应用和有效性。监管部门的核准和医疗保健专业人士对 EPD 益处的认识不断提高，进一步促进了市场的扩张。这些趋势强调了 EPD 在心血管医学中日益增长的重要性，因为它们在提高关键干预措施的安全性和成功率方面继续发挥关键作用。

部分

类型（远端过滤器、近端闭塞、远端闭塞）、应用（心血管疾病、週边血管疾病、神经血管疾病）

受访公司范例（42家值得关注的公司）

  • Abbott Laboratories, Inc.
  • Allium Medical Solutions Ltd.
  • AorticLab
  • Boston Scientific Corporation
  • Cardinal Health UK
  • Contego Medical, Inc.
  • Cordis, a Cardinal Health company
  • Duke Empirical, Inc.
  • Emboline Inc
  • Innovative Cardiovascular Solutions, LLC

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP11766

Global Embolic Protection Devices Market to Reach US$2.1 Billion by 2030

The global market for Embolic Protection Devices estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Distal Filter, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Proximal Occlusion segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$399.9 Million While China is Forecast to Grow at 6.2% CAGR

The Embolic Protection Devices market in the U.S. is estimated at US$399.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$326.8 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.3% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Global Embolic Protection Devices Market - Key Trends and Drivers Summarized

How Are Embolic Protection Devices Revolutionizing Cardiovascular Care?

Embolic protection devices (EPDs) are revolutionizing cardiovascular care by significantly enhancing the safety and efficacy of procedures like percutaneous coronary interventions (PCI) and transcatheter aortic valve replacements (TAVR). These devices are specifically designed to capture and remove embolic debris that may dislodge during these interventions, preventing it from traveling through the bloodstream and causing complications such as stroke, myocardial infarction, or organ damage. By doing so, EPDs mitigate one of the major risks associated with cardiovascular procedures, particularly in high-risk patients who are more susceptible to embolic events. The introduction of these devices has improved patient outcomes by reducing the incidence of procedural complications, thereby making complex cardiovascular treatments safer and more effective. As the global burden of cardiovascular disease continues to rise, the role of embolic protection devices in ensuring patient safety and enhancing procedural success is becoming increasingly important in modern cardiovascular care.

What Innovations Are Enhancing the Functionality of Embolic Protection Devices?

Innovations in embolic protection devices are enhancing their functionality through advancements in design, materials, and integration with other cardiovascular technologies. One of the most significant developments is the miniaturization of these devices, allowing them to be deployed in smaller blood vessels with greater precision and minimal disruption. This is particularly important in procedures like carotid artery stenting, where the risk of stroke is high and precise placement is crucial. Additionally, the use of advanced materials, such as biocompatible polymers and fine mesh filters, has improved the ability of EPDs to capture even the smallest embolic particles without impeding blood flow. This has led to the development of more effective and patient-friendly devices that reduce the risk of complications and improve recovery times. Furthermore, the integration of embolic protection devices with imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is enabling real-time visualization during procedures. This integration allows clinicians to accurately position EPDs and monitor their performance, ensuring optimal protection against embolic events. These innovations are making embolic protection devices more efficient, easier to use, and safer, enhancing their role in a wide range of cardiovascular interventions.

How Do Embolic Protection Devices Impact Patient Outcomes and Procedure Safety?

Embolic protection devices have a profound impact on patient outcomes and procedure safety by significantly reducing the risk of embolic complications during cardiovascular interventions. In procedures such as carotid artery stenting, TAVR, and PCI, the dislodgement of plaque or thrombus can lead to serious complications, including stroke or heart attack. By capturing this debris before it can travel to critical areas like the brain or coronary arteries, EPDs dramatically reduce the incidence of these adverse events. This improved safety profile not only enhances patient outcomes but also expands the pool of patients eligible for minimally invasive cardiovascular procedures, including those who were previously considered high-risk. Moreover, the use of EPDs can lead to shorter hospital stays and quicker recovery times, as patients experience fewer complications and require less intensive postoperative care. For healthcare providers, the reduction in procedural risks and associated complications translates into better overall success rates and potentially lower healthcare costs. By safeguarding against one of the most significant risks in cardiovascular interventions, embolic protection devices are playing a critical role in advancing patient care and improving the safety of life-saving procedures.

What Trends Are Driving Growth in the Embolic Protection Devices Market?

Several trends are driving growth in the embolic protection devices market, including the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, and the continuous advancements in medical technology. The rising incidence of conditions such as atherosclerosis, heart valve diseases, and carotid artery stenosis is leading to an increase in the number of cardiovascular interventions, thereby boosting demand for EPDs. As the global population ages and the burden of cardiovascular diseases grows, the need for safe and effective treatment options is becoming more critical. The shift towards minimally invasive procedures, such as TAVR and carotid artery stenting, is also fueling market growth, as these procedures typically carry a higher risk of embolic events, making EPDs essential for ensuring patient safety. Moreover, ongoing advancements in device design, including the development of next-generation EPDs with enhanced filtration capabilities and improved delivery systems, are expanding the applications and effectiveness of these devices. Regulatory approvals and increasing awareness among healthcare providers about the benefits of EPDs are further contributing to market expansion. These trends underscore the growing importance of embolic protection devices in the field of cardiovascular medicine, as they continue to play a pivotal role in enhancing the safety and success of critical interventions.

SCOPE OF STUDY:

The report analyzes the Embolic Protection Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Distal Filter, Proximal Occlusion, Distal Occlusion); Application (Cardiovascular Diseases, Peripheral Vascular Diseases, Neurovascular Diseases)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories, Inc.
  • Allium Medical Solutions Ltd.
  • AorticLab
  • Boston Scientific Corporation
  • Cardinal Health UK
  • Contego Medical, Inc.
  • Cordis, a Cardinal Health company
  • Duke Empirical, Inc.
  • Emboline Inc
  • Innovative Cardiovascular Solutions, LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Embolic Protection Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Cardiovascular Diseases Drives Demand for Embolic Protection Devices
    • Increasing Adoption of Minimally Invasive Surgical Techniques Bolsters Market Growth
    • Rising Global Health Awareness and Healthcare Access Enhancing Market Opportunities
    • Economic Factors Influencing Healthcare Spending and Device Adoption
    • Development of Next-Generation Embolic Protection Devices for Neurovascular Applications
    • Increasing Incidence of Atrial Fibrillation and Stroke Risk Management
    • Market Influence of Aging Populations on Cardiovascular Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Distal Filter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Distal Filter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Distal Filter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Distal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Distal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Distal Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Proximal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Proximal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Proximal Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Peripheral Vascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Peripheral Vascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Peripheral Vascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Neurovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Neurovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Embolic Protection Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Embolic Protection Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • JAPAN
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • CHINA
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • EUROPE
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Embolic Protection Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Embolic Protection Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • GERMANY
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Rest of Europe 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Asia-Pacific 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of World 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030

IV. COMPETITION